Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
Open Access
- 11 February 2010
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 37 (3), 289-297
- https://doi.org/10.1016/j.nucmedbio.2009.11.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Standardized methods for the production of high specific-activity zirconium-89Nuclear Medicine and Biology, 2009
- Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PETJournal of Nuclear Medicine, 2008
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer PatientsClinical Cancer Research, 2006
- Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometryProtein Science, 2005
- A facile method for the labeling of proteins with zirconium isotopesNuclear Medicine and Biology, 1996
- Site-specific attachment to recombinant antibodies via introduced surface cysteine residuesProtein Engineering, Design and Selection, 1990
- Site-specifically modified 111In labelled antibodies give low liver backgrounds and improved radioimmunoscintigraphyInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- Absorption and Retention of 144Ce and 95Zr-95Nb in Newborn, Juvenile and Adult RatsHealth Physics, 1972